2m 2m 2m 2m 2m 2m 2m
ARCT THERAP HLDG (ARCT)
NASDAQ
$5.92+$0.16 (+2.78%)
Price as of Aug 03, 2026 11:32 AM EDT- $163.7MMarket Cap
- -53.17%1-Year Change
- BiotechnologyIndustry
ARCT THERAP HLDG (ARCT)
$5.92+$0.16 (+2.78%)
ARCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.76 | ||
Change | -$0.16 (-2.70%) | ||
Open | $5.94 | ||
High | $5.96 | ||
Low | $5.64 | ||
Previous Close | $5.92 | ||
Volume | 267,161 | ||
30-Day Average Volume | 539,838 | ||
1-Week Change | 4.16% | ||
1-Month Change | -14.29% | ||
1-Year Change | -53.17% | ||
3-Year Change | -83.52% | ||
5-Year Change | -81.60% | ||
Fundamentals | |||
Shares Outstanding | 28.4M | ||
Total Assets | $245.4M | ||
Market Cap | $163.7M | ||
Enterprise Value | -$47.7M | ||
Period: QTR TTM FY | |||
Revenue | $610,000.00 | ||
Net Income | -$27.0M | ||
Free Cash Flow | -$19.4M | ||
EBIT | -$27.0M | ||
EBITDA | -$26.3M | ||
Net Working Capital | $182.5M | ||
EPS | -$0.95 | ||
Enterprise Value/EBITDA | 2 | ||
Enterprise Value/Revenue | -78 | ||
P/B | 1 | ||
P/E | -6 | ||
PEG | -1 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue